10/5/2026
Psyence partners with Benuvia for ibogaine production
DEA-registered Benuvia to manufacture ibogaine for Psyence in the U.S.
Topic archive
psyence biomedical
4 stories
10/5/2026
AdvisorShares Trust holds 6.78% stake in Psyence Biomedical
The investment firm reports significant ownership in Psyence Biomedical as of September 2026.
9/23/2026
Psyence Biomedical expands with Texas ibogaine unit
Company invests $5 million in PsyLabs for ibogaine research and production.
9/2/2026
Psyence Biomedical files SEC document
The filing could signal strategic developments for the company.